TickerFiles

ADAPTIN BIO, INC. 10-Q filing

Filed 2025-08-14 · Report date 2025-06-30 · 2025

View Original SEC Filing

Filing metadata

Accession number
0001213900-25-076361
Form type
10-Q
CIK
0001938571
Primary document
https://www.sec.gov/Archives/edgar/data/1938571/000121390025076361/ea0252503-10q_adaptin.htm

Extracted primary information

This filing includes deterministic financial metrics extracted from public filing data for ADAPTIN BIO, INC..

Reported financial metrics

MetricCurrentPriorChange
Operating Income$-2.4M--
Net Income$-2.1M--
Eps Basic-0.3--
Eps Diluted-0.3--
Cash And Equivalents$1.4M--
Total Assets$1.7M--
Total Liabilities$1.2M--
Shareholders Equity$474,409--
Operating Cash Flow$-3.3M--